Overview

Corticosteroid Dosage for Crohn's Disease Flare

Status:
Terminated
Trial end date:
2016-12-19
Target enrollment:
Participant gender:
Summary
Prospective randomized comparative effectiveness trial designed to compare fixed dosing and weight-based dosing of corticosteroids in patients with Crohn's disease flares.
Phase:
Phase 4
Details
Lead Sponsor:
Yale University
Treatments:
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Prednisone